doc. MUDr. Igor Kiss, Ph.D., MBA
Department head, Comprehensive Cancer Care Department
Total number of publications: 245
2018
-
Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management
PATHOLOGY & ONCOLOGY RESEARCH, year: 2018, volume: 24, edition: 3, DOI
-
Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, year: 2018, volume: 27, edition: 9, DOI
-
Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis
Targeted Oncology, year: 2018, volume: 13, edition: 6, DOI
-
Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients
Anticancer Research, year: 2018, volume: 38, edition: 1, DOI
-
Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection
CANCER GENOMICS & PROTEOMICS, year: 2018, volume: 15, edition: 4, DOI
2017
-
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
Oncology letters, year: 2017, volume: 14, edition: 1, DOI
-
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
Oncogenesis, year: 2017, volume: 6, edition: 11, DOI
-
Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer
CLINICAL GENITOURINARY CANCER, year: 2017, volume: 15, edition: 6, DOI
-
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
Targeted Oncology, year: 2017, volume: 12, edition: 1, DOI
-
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
BMC Cancer, year: 2017, volume: 17, edition: 880, DOI